IPOs - Spark Newswire

7 minute read

Earnings Pace Picks Up Later Today With Chipotle, Netflix Expected To Report

Today, 3:56 PM

On the day Amazon (NASDAQ: AMZN) founder Jeff Bezos launches himself into space, most investors would probably be happy just to see the major indices pick themselves off the carpet after yesterday’s meltdown.

AAPL

7 minute read

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street

By Shanthi Rexaline

Today, 3:56 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19)

ABIO

1 minute read

IPOs
News

Dynacure Says No Longer Pursuing An IPO Of Its ADSs; Says Files To Withdraw U.S. IPO

By Benzinga Newsdesk

Today, 3:56 PM

-SEC Filing

DYCU

3 minute read

SEC Pushes Harder On SPACs With PSTH Pressure, SRAC Fine

By Chris Katje

Today, 3:56 PM

The SEC has been circling around SPACs in 2021. The company’s pressure on how warrants were recognized by companies led to a backlog of deal votes and company’s set to publicly list. Two SPAC deals have been targeted by the SEC in a move that could change the SPAC market.

PSTH

1 minute read

Duolingo Targeting $3.4B IPO Stemming From Online Learning Boom: Reuters

By Anusuya Lahiri

Today, 3:56 PM

Language-learning app maker Duolingo Inc (NASDAQ:DUOL) is aiming for a $3.41 billion U.S. initial public offering to tap the pandemic-driven…

AAPL

1 minute read

Nervous System Firm Eliem Therapeutics Files For $80M IPO

By Vandana Singh

Today, 3:56 PM

Eliem Therapeutics (NASDAQ: ELYM), a Phase 2a biotech developing therapies for neuronal excitability disorders, filed an IPO prospectus with the SEC to raise up to $80 million. Its two lead candidates are ETX-810 and ETX-155.

ELYM

1 minute read

Skin-Disease Focused Biotech Castle Creek Files $100M IPO

By Vandana Singh

Today, 3:56 PM

Ahead of Phase 3 data readout in the second half of next year, Castle Creek Biosciences Inc (NASDAQ: CCBS) seeks to make NASDAQ debut under the symbol CCBS.

CCBS

2 minute read

FDA-Approved Weight Loss Drug Plenity’s Parent Announces SPAC Deal: What Investors Should Know

By Chris Katje

Today, 3:56 PM

A SPAC deal announced Monday could help accelerate the manufacturing of a promising weight loss drug targeting over 150 million people.

CPSR

1 minute read

Adagio Files $100M IPO To Take Its COVID-19 Antibody Through Commercialization In 2022

By Vandana Singh

Today, 3:56 PM

Adagio Therapeutics has filed an initial public offering to raise money to bring its COVID-19 antibody to market. The $100 million IPO will support Phase 2/3 trials that CEO Tillman Gerngross’ Adagio is running to position ADG20 to treat and prevent COVID-19.

FPX

2 minute read

Fast Radius: Key Takeaways On The SPAC Deal Backed By Goldman Sachs, Palantir

By Chris Katje

Today, 3:56 PM

A disruptive cloud manufacturing and supply chain company announced plans to go public Monday.

APTV